Banner News

Singapore, February 15, 2019 – Credo Diagnostics Biomedical Pte. Ltd., a groundbreaking molecular diagnostic company, announced today they will attend the 91st WVC Conference that will take place in Las Vegas February 17th to 20th.


Credo Diagnostics will be introducing doing live demo of of CUBE PCR, its revolutionary point-of-care molecular diagnostic solution, for the first time to the Veterinary community in the USA. Using a proprietary Real Time PCR technology, the CUBE PCR is an affordable, user friendly and reliable solution that provides diagnostic results in only 15 minutes from a variety of sample types (feces, blood, oral fluid, etc.).


Credo Diagnostics will be located at the booth #1624, where it will be meeting with individual veterinarians, scholars, veterinary associations, and potential business partners.


About Credo Diagnostics Biomedical Pte. Ltd.

Credo Diagnostics develops and manufactures innovative, easy-to-use and rapid molecular diagnostic solutions for Point-of-Care (POC) applications at affordable costs without compromising accuracy and speed in the areas Human Health. Leveraging solid and established science, combined with efficient integration and strategic innovation, Credo Diagnostics Biomedical provides advanced medical technologies for all.



We at Credo Diagnostics pioneer accessible diagnostic platforms to improve the lives of those we love. We believe providing the right information to the right people at the right time leads to better outcomes.